Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ads free!Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ads free today!Spring sale! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Regeneron
Health
Diabetes
Disability
Heart Disease
Diet and Fitness
Cancer
Mental Health
Reproductive Health
Obesity
Topics

Advertisement

Regeneron

Share

Top Latest Popular

🗞️ NEWSNOW ESSENTIALS | Support independent news discovery ads free, just £2.99 a month!

🗞️ NEWSNOW ESSENTIALS | Go ads free and support independent news discovery for just £2.99 a month! Upgrade today!

Yesterday

Saudi Arabia Competes at Regeneron ISEF 2026 with 40 Students Riyadh Daily 19:34 Tue, 12 May

Monday

Spotlight On: Biosimilar Litigations - May 2026 JD Supra 19:16 Mon, 11 May

Friday

Assessing Regeneron (REGN) After Recent Share Price Weakness And Strong Valuation Signals Simply Wall St 22:59 Fri, 08 May

Advertisement

Advertisement

La Vega’s David Martinez to represent Waco at world’s largest pre-college stem fair KWTX 13:39 Fri, 08 May

Regeneron Named to Dow Jones Best-in-Class World Index for Global Responsibility Leadership for Seven Consecutive Years Regeneron Pharmaceuticals (Press Release) 12:07 Fri, 08 May

Is This Biotech Stock a Buy After a Groundbreaking Approval? The Motley Fool 09:01 Fri, 08 May

In the last month

Does Regeneron’s Gene Therapy Milestone and Buyback Shift the Bull Case For Regeneron Pharmaceuticals (REGN)? Simply Wall St 07:02 Wed, 06 May

Zifo's SiEE Boston Summit Charts New Roadmap for 'Practical AI' in Life Sciences, Bridging the Gap Between Business Vision and Lab Reality PR Newswire (Press Release) 14:09 Tue, 05 May

LIMERICK IN PHOTOS: Record-breaking year as over 20,000 take part in 2026 Great Limerick Run Limerick Post 13:37 Tue, 05 May

One More Iffy Trump Drug Deal CounterPunch 06:49 Mon, 04 May

Weekly reads: Gene therapy for rare form of deafness free from Regeneron, Osk in the heart, real-time clinical trials The Niche (Weblog) 09:03 Sun, 03 May

Is Regeneron a Buy After the FDA Approved its Gene Therapy to Restore Hearing? The Motley Fool 16:25 Sat, 02 May

Regeneron Advances In Vivo Gene Therapy For Hearing Loss Drugs Discovery Online 20:11 Fri, 01 May

Bristol Myers’ legacy lift, Biogen’s blue skies and Regeneron’s murky outlook BioPharma Dive 15:54 Fri, 01 May

Regeneron Presses Amgen for Eylea Antitrust Damages Evidence Bloomberg Law 21:29 Thu, 30 Apr

Regeneron Pharmaceuticals Analysts Cut Their Forecasts Following Q1 Earnings Benzinga 17:47 Thu, 30 Apr

Advertisement

CRISPR Genome Editing and the Future of Down Syndrome Treatment Reason 16:43 Thu, 30 Apr

Regeneron Q1 2026 net income falls 10% to $727m Pharmaceutical Technology 09:34 Thu, 30 Apr

Regeneron Flags FDA Delays For Eylea HD Prefilled Syringe Benzinga 19:02 Wed, 29 Apr

The FDA Approves the First-Ever Gene Therapy for Deafness, Which Aims to Restore Hearing in Kids With a Rare Inherited Condition Smithsonian Magazine 19:00 Wed, 29 Apr

Regeneron Q1 Earnings Top, Sales Up on Dupixent & Eylea HD Strength Zacks 18:36 Wed, 29 Apr

Regeneron’s Pipeline In Focus As Fianlimab Melanoma Data Awaited Scrip Pharma Intelligence 18:31 Wed, 29 Apr

Regeneron's quarterly sales of Eylea drop below $1B for the first time in 8 years FiercePharma 17:15 Wed, 29 Apr

Regeneron Pharmaceuticals Stock Falls 6% Over Decline In Q1 Earnings RTT News 15:38 Wed, 29 Apr

Regeneron (REGN) Reports Q1 Earnings: What Key Metrics Have to Say Zacks 15:32 Wed, 29 Apr

Regeneron shares slide despite Q1 beat Proactive Investors (US) 15:16 Wed, 29 Apr

Regeneron (REGN) Surpasses Q1 Earnings and Revenue Estimates Zacks 13:50 Wed, 29 Apr

Regeneron Reports First Quarter 2026 Financial and Operating Results Regeneron Pharmaceuticals (Press Release) 11:30 Wed, 29 Apr

Otarmeni Regeneron’s first genetic medicine to gain approval European Pharmaceutical Review 11:32 Tue, 28 Apr

Regeneron Strikes Deal With Trump Administration To Cut Drug Prices Benzinga 17:12 Fri, 24 Apr

Gear Up for Regeneron (REGN) Q1 Earnings: Wall Street Estimates for Key Metrics Zacks 15:25 Fri, 24 Apr

Cure for deafness: Breakthrough gene drug Otarmeni set to be offered free to American children with total hearing loss following FDA approval MailOnline 15:03 Fri, 24 Apr

STAT Plus: Pharmalittle: We’re reading about a Trump deal with Regeneron, reclassifying medical marijuana, and more STAT 14:45 Fri, 24 Apr

List of Drugs That Could See Massive Price Cuts Under Trump Deal Miami Herald 12:04 Fri, 24 Apr

Regeneron Agrees To Lower Prescription Drug Prices Under Mfn Deal RTT News 12:03 Fri, 24 Apr

Regeneron cuts White House pricing deal, offers new gene therapy for free Pharmaceutical Technology 11:22 Fri, 24 Apr

FDA clears first genetic hearing loss gene therapy pharmaphorum 10:24 Fri, 24 Apr

Regeneron Pharma: FDA Grants Approval For Otarmeni, Gene Therapy For Genetic Hearing Loss RTT News 05:23 Fri, 24 Apr

Regeneron agrees to lower US drug prices under Trump pricing initiative The Hindu Business Line 03:52 Fri, 24 Apr

Trump unveils new drug price deal with Regeneron amid affordability push The Washington Post 01:43 Fri, 24 Apr

Advertisement

Advertisement

Regeneron News

Latest news and updates on Regeneron Pharmaceuticals, an American biotechnology company that was founded in 1988. The company is listed on NASDAQ.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Health Health
Back to Lifestyle Health
- Diet and Fitness
- Mental Health
- Cancer Cancer
- Diabetes Diabetes
- Disability Disability
- Gastrointestinal Diseases
- Infectious Diseases
- Neurological Diseases
- Reproductive Health
- Sexual Health
- Allergies Allergies
- Alopecia Alopecia
- Antibiotic Resistance
- Assisted Dying
- Blood Disorders
- Heart Disease
- Obesity Obesity
- PTSD PTSD
- Rare Diseases
- SIDS SIDS